Cancer drug reduces early Alzheimer's-like brain hyperconnectivity in lab tests

Neuroscientists at King’s College London have pinpointed a mechanism behind the increased neural connectivity observed in the very early stages of Alzheimer’s disease. Published in Translational Psychiatry, the study also demonstrated that a…

Continue Reading

News Source: medicalxpress.com